#1
#1 out of 1
health22h ago
Health Rounds: Experimental drug shows promise for stroke patients who miss the current medical treatment window
- Mid-stage trial shows SCP776 may help stroke patients outside the usual treatment window.
- The drug works by delivering IGF-1 to activate brain repair pathways.
- FDA granted Fast Track designation for SCP776 for acute ischemic strokes.
- AI software improves fetal heart defect detection in second-trimester ultrasounds.
- AI-assisted results came from BrightHeart technology across multiple centers.
- Study suggests AI could reduce global variability in detecting congenital defects.
- Researchers published findings in Obstetrics & Gynecology and reported at the World Stroke Congress.
- Stroke patients in the trial were treated about 12 hours after onset on average.
- The trial saw higher functional independence at 90 days for SCP776 recipients.
Vote 0